Thanks
Health Professional
Adding to what Dr Gwynne wrote, this link describes the clinical trial that Dr Ralph and his colleagues are about to carry out concerning Enteracapt and Alzheimer's Disease:
http://www.griffith.edu.au/health/griffith-health-institute/research/alzheimers-trial
The trial has research ethics approval but is restricted to people who are 78 y.o. or more.
Depending on the results of the trial, Enteracapt may be added to the PBS-approved list of Alzheimer's Disease medications.
You must be a HealthShare member to report this post.
to your account or now (it's free).